Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
40.29
+0.39 (0.98%)
Jan 17, 2025, 4:00 PM EST - Market closed
Revolution Medicines Employees
Revolution Medicines had 378 employees as of December 31, 2023. The number of employees increased by 132 or 53.66% compared to the previous year.
Employees
378
Change (1Y)
132
Growth (1Y)
53.66%
Revenue / Employee
$1,963
Profits / Employee
-$1,500,161
Market Cap
7.45B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 378 | 132 | 53.66% |
Dec 31, 2022 | 246 | 58 | 30.85% |
Dec 31, 2021 | 188 | 63 | 50.40% |
Dec 31, 2020 | 125 | 30 | 31.58% |
Dec 31, 2019 | 95 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
RVMD News
- 14 days ago - Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 6 weeks ago - Revolution Medicines: Risky Buy On Recent Share Price Dip - Seeking Alpha
- 6 weeks ago - Top 3 Health Care Stocks That Could Blast Off In December - Benzinga
- 6 weeks ago - Revolution Medicines Announces Pricing of Upsized $750.0 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 7 weeks ago - Revolution Medicines Announces Commencement of Public Offering of Common Stock - GlobeNewsWire
- 7 weeks ago - Revolution Medicines Provides Clinical Updates from its RAS(ON) Inhibitor Portfolio - GlobeNewsWire
- 7 weeks ago - Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024 - GlobeNewsWire